News
- Author:
- Susan London
Publish date: July 5, 2017
Death rates were lowered in women assigned to a low-fat diet after breast cancer diagnosis.
News
- Author:
- Susan London
Publish date: June 29, 2017
Patients with sickle cell disease had reduced levels of HDL3 and altered functionality of HDL2, which were associated with an increased lipoprotein...
News
- Author:
- Susan London
Publish date: June 27, 2017
CHICAGO – In a phase II trial, patients given FOLFOX chemotherapy and bevacizumab plus high-dose vitamin D had a one-third lower risk of progressio...
News
- Author:
- Susan London
Publish date: June 23, 2017
CHICAGO – The efficacy of ibrutinib is durable for patients with relapsed chronic lymphocytic leukemia (CLL), and combination strategies are showin...
News
- Author:
- Susan London
Publish date: June 19, 2017
CHICAGO – In a phase III randomized controlled trial of more than 1,500 patients who had undergone nephrectomy for high-risk locally advanced RCC, ...
News
- Author:
- Susan London
Publish date: June 14, 2017
CHICAGO – Men with low testosterone in a cohort study of 491 testicular cancer survivors were more likely to be taking medications for dyslipidemia...
News
- Author:
- Susan London
Publish date: June 8, 2017
CHICAGO – The OlympiAD trial represents a “major step forward in breast cancer” in terms of both translational medicine and precision medicine.
News
- Author:
- Susan London
Publish date: June 5, 2017
An analysis of three trials involving 55 patients with advanced cancer harboring TRK fusions who were treated with larotrectinib showed an overall ...
News
- Author:
- Susan London
Publish date: June 4, 2017
In phase III results, olaparib reduced the risk of progression or death in women with BRCA-related HER2-negative metastatic breast cancer, compared...
Video
- Author:
- Susan London
Publish date: June 4, 2017
CHICAGO – Lead study investigator David Hyman, MD, discusses the integrated analysis of three larotrectinib trials and the drug’s regulatory status...
News
- Author:
- Susan London
Publish date: June 3, 2017
CHICAGO – “A single dose has enormous advantages in those patients with short survival times.”
News
- Author:
- Susan London
Publish date: June 3, 2017
CHICAGO – Survivors with hypogonadism are more likely than survivors with normal testosterone levels to have a range of chronic health problems.
Video
- Author:
- Susan London
Publish date: June 3, 2017
A single dose of radiation therapy works essentially as well as multiple doses for treating spinal cord compression resulting from cancer metastase...
News
- Author:
- Susan London
Publish date: May 25, 2017
A study in a diverse population of pregnant women with preeclampsia has identified several risk factors for pregnancy-associated stroke.
News
- Author:
- Susan London
Publish date: May 23, 2017
HPV vaccination appears to confer a high level of protection against oral infection with oncogenic virus types.
